NEKTAR THERAPEUTICS shareholders Q1 2021

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

NEKTAR THERAPEUTICS shareholders Q1 2021
NameSharesValueWeighting ↓
McClarren Financial Advisors, Inc. 157$3,0000.00%
DekaBank Deutsche Girozentrale 54,000$1,050,0000.00%
SIGNATUREFD, LLC 3,362$67,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 19,607$392,0000.00%
TEACHER RETIREMENT SYSTEM OF TEXAS 19,866$397,0000.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 18,638$373,0000.00%
Penserra Capital Management LLC 4,120$82,0000.00%
Squarepoint Ops LLC 19,695$394,0000.00%
MORGAN STANLEY 519,131$10,384,0000.00%
WOLVERINE TRADING, LLC 51,700$1,009,0000.00%
Legal & General Group Plc 264,768$5,295,0000.00%
BNP PARIBAS FINANCIAL MARKETS 70,884$1,417,680,0000.00%
ALLIANCEBERNSTEIN L.P. 283,194$5,664,0000.00%
Bridgewater Associates 11,063$221,0000.00%
ATLAS CAPITAL ADVISORS LLC 600$12,000,0000.00%
CREDIT SUISSE AG/ 210,036$4,200,0000.00%
OSAIC HOLDINGS, INC. 34,061$681,0000.00%
VIRGINIA RETIREMENT SYSTEMS ET AL 12,700$254,0000.00%
GOLDMAN SACHS GROUP INC 459,974$9,200,0000.00%
UBS ASSET MANAGEMENT AMERICAS LLC 252,586$5,051,720,0000.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.